News & Resources
Addressing the Emergent Issue of Long COVID
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some [read more...]
Decode Health Expands Strategic Advisory Board
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO [read more...]
Local Startup Develops AI Platform for Predicting COVID-19 Trends
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.
As Seen In
Publications
Podcasts
News
MS & AI with Dr. Chase Spurlock, CEO of IQuity
Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and CEO of IQuity talks about how IQuity is using its expertise in machine learning to [read more...]
JULIA POLK: HOW TO TAKE A CAREER BREAK AND COME BACK CONFIDENT
Julia explains why she was lucky to have female role models early in her career and what she did to stay connected during her extended breaks from the workforce. She also tells us about the value of diversity in leadership teams, the issues women face in raising capital for a [read more...]
Using Data Analytics to Predict, Detect and Monitor Chronic Autoimmune Diseases
According to the American Autoimmune Related Diseases Association, autoimmune diseases are among the most prevalent diseases in the U.S., affecting approximately 50 million Americans — or 20 percent of the population. Among the 80–100 different types of autoimmune diseases that have been identified by researchers, annual direct health care costs add up to around $100 [read more...]
Blog
Addressing the Emergent Issue of Long COVID
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. Commonly referred to as long COVID, scientists are just beginning to understand the long-term [read more...]
Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders
Everyone knows at least one person with an autoimmune disease or disorder and just may not know it. Even if you think you don’t, you most likely do, considering autoimmune diseases affect approximately 50 million Americans while cancer affects 15 million. Both diseases substantially impact society, but how do we [read more...]